Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Jonathan Bock MD

Jonathan Bock MD

Assistant Professor

Institution: Medical College of Wisconsin
Department: Otolaryngology
Program: Adult


Research Experience

  • Carcinoma, Squamous Cell
  • Head and Neck Neoplasms
  • Larynx
  • National Institute on Deafness and Other Communication Disorders (U.S.)
  • Voice
  • Voice Disorders
  • Clinical Expertise

  • Head and Neck Neoplasms
  • Otolaryngology
  • Voice Disorders
  • Publications

  • Arytenoid repositioning device. (Hoffman HT, Heaford AC, Dailey SH, Bock JM, Van Daele DJ, Ahlrichs-Hanson JS, Quebbemann GJ, Johnson MN, Boltz JE, Tiedt SL) Ann Otol Rhinol Laryngol 2014 Mar;123(3):195-205 PMID 24633946
  • Restructuring the vocal fold lamina propria with endoscopic microdissection. (Bartlett RS, Hoffman HT, Dailey SH, Bock JM, Klemuk SA, Askeland RW, Ahlrichs-Hanson JS, Heaford AC, Thibeault SL) Laryngoscope 2013 Nov;123(11):2780-6 PMID 23959803
  • Systemic sclerosis and reflux. (Petronovich JJ, Bock JM) Ear Nose Throat J 2013 Apr-May;92(4-5):192-4 PMID 23599100
  • Mitochondrial myopathy: a rare cause of early-onset vocal fold atrophy. (Kelly EA, Bock JM, Peltier AC, Oh SJ, Garrett CG) Ann Otol Rhinol Laryngol 2013 Mar;122(3):177-82 PMID 23577570
  • Botulinum toxin injection for the treatment of upper esophageal sphincter dysfunction. (Kelly EA, Koszewski IJ, Jaradeh SS, Merati AL, Blumin JH, Bock JM) Ann Otol Rhinol Laryngol 2013 Feb;122(2):100-8 PMID 23534124
  • Massive Zenker diverticulum. (Bock JM, Petronovich JJ, Blumin JH) Ear Nose Throat J 2012 Aug;91(8):319-20 PMID 22930080
  • Dysphagia due to adenoid cystic carcinoma of the base of the tongue. (Hoekzema CR, Massey BL, Blumin JH, Hunt BC, Bock JM) Ann Otol Rhinol Laryngol 2012 Jun;121(6):402-6 PMID 22737963
  • Pepsin promotes proliferation of laryngeal and pharyngeal epithelial cells. (Johnston N, Yan JC, Hoekzema CR, Samuels TL, Stoner GD, Blumin JH, Bock JM) Laryngoscope 2012 Jun;122(6):1317-25 PMID 22570308
  • Reactive intracordal fibrovascular lesion. (Leach ME, Blumin JH, He C, Bock JM) Ear Nose Throat J 2012 Feb;91(2):54-6 PMID 22359128
  • Management of Zenker's diverticulum in the endoscopic age: current practice patterns. (Bock JM, Van Daele DJ, Gupta N, Blumin JH) Ann Otol Rhinol Laryngol 2011 Dec;120(12):796-806 PMID 22279951
  • Feasibility and acute healing of vocal fold microflap incisions in a rabbit model. (Suehiro A, Bock JM, Hall JE, Garrett CG, Rousseau B) Laryngoscope 2012 Mar;122(3):600-5 PMID 22253007
  • Extra-esophageal refllux disease: perspectives from a translational research team (Bock, JM, Johnston, N, Koszewski, IJ, Toohill, RJ, Blumin, JH) Perspectives in Voice and Voice Disorders 21(3):118-123, November 2011
  • Serum immunoglobulin G analysis to establish a delayed diagnosis of chronic cough due to Bordetella pertussis. (Bock JM, Burtis CC, Poetker DM, Blumin JH, Frank MO) Otolaryngol Head Neck Surg 2012 Jan;146(1):63-7 PMID 21987649
  • Analysis of pepsin in tracheoesophageal puncture sites. (Bock JM, Brawley MK, Johnston N, Samuels T, Massey BL, Campbell BH, Toohill RJ, Blumin JH) Ann Otol Rhinol Laryngol 2010 Dec;119(12):799-805 PMID 21250551
  • A new noninvasive method for determination of laryngeal sensory function. (Bock JM, Blumin JH, Toohill RJ, Merati AL, Prieto TE, Jaradeh SS) Laryngoscope 2011 Jan;121(1):158-63 PMID 21120827
  • Microendoscopy of Reinke's space. (Hoffman HT, Bock JM, Karnell LH, Ahlrichs-Hanson J) Ann Otol Rhinol Laryngol 2008 Jul;117(7):510-4; discussion 515-6 PMID 18700426
  • Coblation-assisted lingual tonsillectomy for dysphagia secondary to tongue base hypertrophy. (Bock JM, Trask DK) Ann Otol Rhinol Laryngol 2008 Jul;117(7):506-9 PMID 18700425
  • Modulation of cellular invasion by VEGF-C expression in squamous cell carcinoma of the head and neck. (Bock JM, Sinclair LL, Bedford NS, Jackson RE, Lee JH, Trask DK) Arch Otolaryngol Head Neck Surg 2008 Apr;134(4):355-62 PMID 18427000
  • Migration of Cymetra after vocal fold injection for laryngeal paralysis. (Bock JM, Lee JH, Robinson RA, Hoffman HT) Laryngoscope 2007 Dec;117(12):2251-4 PMID 17909445
  • Celecoxib toxicity is cell cycle phase specific. (Bock JM, Menon SG, Sinclair LL, Bedford NS, Goswami PC, Domann FE, Trask DK) Cancer Res 2007 Apr 15;67(8):3801-8 PMID 17440094
  • Relative non-steroidal anti-inflammatory drug (NSAID) antiproliferative activity is mediated through p21-induced G1 arrest and E2F inhibition. (Bock JM, Menon SG, Goswami PC, Sinclair LL, Bedford NS, Domann FE, Trask DK) Mol Carcinog 2007 Oct;46(10):857-64 PMID 17415779
  • Differential activity of sulindac metabolites against squamous cell carcinoma of the head and neck is mediated by p21waf1/cip1 induction and cell cycle inhibition. (Bock JM, Menon SG, Goswami PC, Sinclair LL, Bedford NS, Jackson RE, Trask DK) Cancer Biol Ther 2007 Jan;6(1):30-9 PMID 17172818
  • Modulation of tumor cell proliferation and apoptosis by polyamine depletion in cells of head and neck squamous cell carcinomas. (Bock JM, Pickart MA, Pink JJ, Harari PM) Radiat Res 1999 Dec;152(6):604-10 PMID 10581530
  • Epidermal growth factor receptor blockade with C225 modulates proliferation, apoptosis, and radiosensitivity in squamous cell carcinomas of the head and neck. (Huang SM, Bock JM, Harari PM) Cancer Res 1999 Apr 15;59(8):1935-40 PMID 10213503
  • Grants and Awards

  • Clinical and Translational Science Award (#9207526 04/01/2012 - 03/31/2015) PI of CTSI Pilot - Understanding Mechanisms of Celecoxib Toxicity in Squamous Cell Carcinoma of the Head and Neck through (#2207910)